FindTrial
Sign In

Intravenous fluid management in patients with acute hypertensive hemorrhagic stroke: A randomized controlled study

Clinical outcome in patients with acute hypertensive hemorrhagic stroke with intravenous fluid versus no intravenous fluid: A randomized controlled study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/02/031504
Enrollment
210
Registered
2021-02-23
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I61- Nontraumatic intracerebral hemorrhage Health Condition 2: I613- Nontraumatic intracerebral hemorrhage in brain stem Health Condition 3: I614- Nontraumatic intracerebral hemorrhage in cerebellum Health Condition 4: I611- Nontraumatic intracerebral hemorrhage in hemisphere, cortical Health Condition 5: I610- Nontraumatic intracerebral hemorrhage in hemisphere, subcortical Health Condition 6: I612- Nontraumatic intracerebral hemorrhage in hemisphere, unspecified Healt

Interventions

Intervention1: Intravenous fluid: 0.9% NaCl solution will be administered intravenously at a rate of 100ml/hr for the first 72 hrs. They will be encouraged to take same amount of fluid orally or throu

Sponsors

Institute of Medical Sciences Banaras Hindu University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All the patients admitted to our hospital with acute hypertensive hemorrhagic stroke (based on clinical and radiological features) within a period of 72hrs from the onset of symptoms and consenting to be part of the study will be included after screening for inclusion and exclusion criteria.

Exclusion criteria

Exclusion criteria: 1.Not willing to participate in the study or no informed consent. 2.Those with GCS less than or equal to 8 at admission. 3.Prepared for or received surgical intervention within 14 days. 4.Patients with co-morbid conditions like cardiac failure, low ejection fraction ( 5.Patients with sepsis, hypotension, DKA, electrolyte disturbances requiring urgent correction, requiring ICU admission or those with critical illness. 6.Life expectancy or any reasons for follow-up 7.Those who received fluid from other hospital before reaching our hospital.

Design outcomes

Primary

MeasureTime frame
Proportion of patients with good outcome defined by mRS score of 0-3Timepoint: 3 months—

Secondary

MeasureTime frame
Cardiac failure or evidence of fluid overloadTimepoint: Within 4days;Dehydration during hospital stayTimepoint: Till discharge;Duration of hospital stayTimepoint: At discharge;Worsening of NIHSS score by more than or equal to 3 points unexplained by another causeTimepoint: Within 4days—

Countries

India

Contacts

Public ContactDr Favas T T

Institute of Medical Sciences, Banaras Hindu University

abhishekpathakaiims@gmail.com8948512666

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026